These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 6442228)
1. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy. Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228 [TBL] [Abstract][Full Text] [Related]
2. Levels of serum angiotensin-converting enzyme before and after forearm venous stasis in diabetic microangiopathy. Porta M; Passera P; Bertagna A; La Selva M; Ricchetti I; Molinatti GM Diabetes Res; 1987 Mar; 4(3):117-20. PubMed ID: 3038452 [TBL] [Abstract][Full Text] [Related]
3. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
4. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
5. The ultrastructural localization of von Willebrand factor in endothelial cells. Warhol MJ; Sweet JM Am J Pathol; 1984 Nov; 117(2):310-5. PubMed ID: 6093546 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease. Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740 [TBL] [Abstract][Full Text] [Related]
7. [Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)]. Mazurier C; Parquet-Gernez A; Goudemand M Pathol Biol (Paris); 1977 Dec; 25 Suppl():18-24. PubMed ID: 353655 [TBL] [Abstract][Full Text] [Related]
8. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation]. Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063 [TBL] [Abstract][Full Text] [Related]
9. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results]. Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207 [TBL] [Abstract][Full Text] [Related]
10. Factor VIII, von Willebrand factor and platelet adhesiveness in diabetic retinopathy. Nozaki H; Hiramatsu K; Arimori S Tokai J Exp Clin Med; 1987 Mar; 12(1):7-9. PubMed ID: 3130682 [TBL] [Abstract][Full Text] [Related]
11. Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation. Kalyoncu U; Dizdar O; Erkan Duman A; Karadag O; Tufan A; Yucel O; Tayfur O; Sen D; Ulger Z; Kepez A; Kocabas U; Haznedaroglu I Clin Appl Thromb Hemost; 2009 Feb; 15(1):103-8. PubMed ID: 18160605 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120). Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein. Fukui H; Yoshioka A; Mikami S; Takase T; Fujimura Y; Takahashi Y; Nishino M; Iwagaki K Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):839-50. PubMed ID: 121660 [No Abstract] [Full Text] [Related]
15. [Factor VIII (von Willebrand antigen) in patients with acquired thrombocytopathies]. Genova V; Baleva M; Nikolov K Vutr Boles; 1987; 26(2):82-5. PubMed ID: 3111097 [TBL] [Abstract][Full Text] [Related]
16. Lack of von Willebrand factor, factor VIII related antigen and factor VIII coagulant response to human growth hormone infusion in type 2 diabetes mellitus. Grecu EO; Sheikholislam BM; Abildgaard CF Am J Med Sci; 1984; 287(2):3-6. PubMed ID: 6424471 [TBL] [Abstract][Full Text] [Related]
17. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions]. Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351 [No Abstract] [Full Text] [Related]
18. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078 [TBL] [Abstract][Full Text] [Related]
19. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules. Furlan M; Perret BA; Beck EA Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738 [TBL] [Abstract][Full Text] [Related]
20. Possible evidence for an increased factor VIII antigen synthesis in vascular endothelium of diabetic subjects. Giustolisi R; Musso R; Russo M; Catania N; Lombardo T; Cacciola E Thromb Haemost; 1982 Jun; 47(3):293. PubMed ID: 6810491 [No Abstract] [Full Text] [Related] [Next] [New Search]